Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000005

EVP, Chief Scientific Officer acquired 19,428 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

ALTSHULER DAVID · EVP, Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2025-02-04 Grant or award : show line 1 in the form +12,314 38,127 D
2025-02-04 Grant or award : show line 2 in the form +7,114 45,241 D
Loading xslF345X05/wk-form4_1738876056.xml…